Nanoencapsulation as a way to control the release and to increase the photostability of clobetasol propionate: Influence of the nanostructured system

Journal of Biomedical Nanotechnology

Volumn 5, Issue 3, 2009, Pages 254-263

  Fontana, M C ^a   Coradini, K ^a   Guterres, S S ^b   Pohlmann, A R ^c   Beck, R C R ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Clobetasol propionate; In vitro drug release; Nanocapsules; Nanoemulsions; Nanoparticles; Photostability

Indexed keywords

BURST RELEASE; CLOBETASOL PROPIONATE; CONTROLLED RELEASE; DRUG CONTENT; ENCAPSULATION EFFICIENCY; IN VITRO DRUG RELEASE; IN-VITRO; MEAN SIZE; NANO-ENCAPSULATION; NANOEMULSION; NANOEMULSIONS; NANOMETRICS; NANOSTRUCTURED SYSTEMS; NEGATIVE ZETA POTENTIALS; NEUTRAL PH; PHOTOSTABILITY; PHYSICOCHEMICAL CHARACTERISTICS; POLYDISPERSITY INDICES; POLYMERIC NANOPARTICLES; ROOM TEMPERATURE; UVA RADIATION;

DIALYSIS; NANOCAPSULES; NANOPARTICLES; NANOSPHERES; POLYDISPERSITY; ZETA POTENTIAL;

ENCAPSULATION;

CLOBETASOL PROPIONATE; NANOPARTICLE; NANOSPHERE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; IN VITRO STUDY; NANOEMULSION; NANOENCAPSULATION; PH; ROOM TEMPERATURE; STRUCTURE ACTIVITY RELATION; ZETA POTENTIAL;

CLOBETASOL; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG STABILITY; LIGHT; MATERIALS TESTING; NANOSTRUCTURES; PARTICLE SIZE; WATER;

EID: 69249183406     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2009.1030     Document Type: Article

References (45)

1. British National Formulary, London: British Medical Association and the Royal Pharmaceutical Society of Great Britain (2004).
2. S. Wiedersberg, C. S. Leopold, and R. H. Guy, Bioavailability and bioequivalence of topical glucocorticoids. Eur. J. Pharm. Biopharm. 68, 453 (2008).
3. L. Gagliardi, D. Orsi, M. R. Giudice, F. Gatta, R. Porrà, P. Chimenti, and D. Tonelli, Development of a tandem thin-layer chromatography-high-performance liquid chromatography method for the identification and determination of corticosteroids in cosmetic products. Anal. Chim. Acta 457, 187 (2002).
4. J. S. Kao, J. W. Fluhr, M. -Q. Man, A. J. Fowler, J. -P. Hachem, D. Crumrine, S. K. Ahn, B. E. Brown, P. M. Elias, and K. R. Feingold, Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: Inhibition of epidermal lipid synthesis account for functional abnormalities. J. Invest. Dermatol. 120, 456 (2003).
5. J. Iqbal, A. Gupta, and A. Husain, Photochemistry of clobetasol propionate, A steroidal anti-inflammatory drug. ARKIVOC xi 97 (2006).
6. S. R. Schaffazick, L. L. Freitas, A. R. Pohlmann, and S. S. Guterres, Caracterização e estabilidade fisico-quimica de sistemas poliméricos nanoparticulados para administração de fármacos. Quim. Nova 25, 726 (2003).
7. P. Calvo, J. L. Vila-Jato, and M. J. Alonso, Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules and nanoemulsions, as ocular drug carrier. J. Pharm. Sci. 85, 530 (1996).
8. S. R. Schaffazick, A. R. Pohlmann, C. A. S. Cordova, T. B. Creczynski-Pasa, and S. S. Guterres, Protective properties of melatonin-loaded nanoparticles against lipid peroxidation. Int. J. Pharm. 289, 209 (2005).
9. M. P. Alves, A. L. Scarrone, M. Santos, A. R. Pohlmann, and S. S. Guterres, Human skin penetration and distribuition of nimesulide from hydrophilic gels containing nanocarriers. Int. J. Pharm. 341, 215 (2007).
10. C. S. Maia, W. Mehnert, M. Schäfer-Körting, Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int. J. Pharm. 196, 165 (2000).
11. P. Perugini, S. Simeoni, S. Scalia, I. Genta, T. Modena, B. Conti, and F. Pavanetto, Effect of nanoparticle encapsulation on the photostability of the sunscreen agent, 2-ethylhexyl-p-methoxycinnamate. Int. J. Pharm. 246, 37 (2002).
12. G. Ioele, E. Cione, A. Risoli, G. Genchi, and G. Ragno, Accelerated photostability study of tretinoin and isotretinoin in liposome formulations. Int. J. Pharm. 293, 251 (2005).
13. A. F. Ourique, A. R. Pohlmann, S. S. Guterres, and R. C. R. Beck, Tretinoin-loaded nanocapsules: Preparation, physicochemical characterization, and photostability study. Int. J. Pharm. 352, 1 (2008).
14. J. S. Almeida, L. Jezur, M. C. Fontana, K. Pease, C. B. Silva, A. R. Pohlmann, S. S. Guterres, and R. C. R. Beck, Oil-based nanoparticles containing alternative vegetable oils (grape seed oil and almond kernel oil): Preparation and characterization. Lat. Am. J. Pharmacy 28, 165 (2009).
15. M. Kalariya, B. K. Padhi, M. Chougule, and A. Misra, Clobetasol propionate solid lipid nanoparticles cream for effective treatment if eczema: Formulation and clinical implications. Indian J. Exp. Biol. 43, 233 (2005).
16. G. Campisi, G. Giandalia, V. Caro, C. Liberto, P. Arićo, and L. I. Giannola, A new delivery system of clobetasol-17-propionate (lipid- loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial. Brit. J. Dermatol. 150, 984 (2004).
17. G. Rao and R. Murthy, Evaluation of liposomal clobetasol propionate topical formulation for intra-dermal delivery. Indian J. Pharm. Sci. 62, 459 (2000).
18. J. I. T. Capó, X. P. Gutiérrez, and C. C. Dominguez, Incremento de la actividad timolítica del clobetasol em forma liposomal. Rev. Cubana Farm. 38, 2 (2004).
19. F.-Q. Hu, H. Yuan, H. H. Zhang, M. Fang, Preparation of solid lipid nanoparticles qith clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int. J. Pharm. 239, 121 (2002).
20. F.-Q. Hu, S.-P. Jiang, Y.-Z. Du, H. Yuan, Y.-Q. Ye, and S. Zeng, Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf. B: Biointerf. 45, 167 (2005).
21. F.-Q. Hu, S.-P. Jiang, Y.-Z. Du, H. Yuan, Y.-Q. Ye, and S. Zeng, Preparation and characterization of monostearin nanostructured lipid carriers. Int. J. Pharm. 214, 83 (2006).
22. H. Yuan, L.-F. Huang, Y.-Z. Du, X.-Y. Ying, J. You, F.-Q. Hu, and S. Zeng, Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids Surf. B: Biointerf. 61, 132 (2008).
23. S. S. Soppimath, T. M. Aminabhavi, A. R. Kulkami, and W. E. Rudzinski, Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 70, 1 (2001).
24. H. Fessi, F. Puisieux, and J. P. Devissaguet, Procédé de préparation dês systèmes coloïdaux d'une substance, sous forme de nanocapsules. European Patent 0274961 A1 (1988a).
25. H. Fessi, J. P. Devissaguet, F. Puisieux, C. Thies, Procédé de préparation dês systèmes coloïdaux d'une substance sous forme du nanoparticles. European Patent 0275796 A1 (1988b).
26. E. Martini, E. Carvalho, H. Teixeira, Adsorção de oligonucleotídeos em nanoemulsões obtidas por emulsificaç ão espontânea. Quim. Nova 30, 930 (2007).
27. M. C. Fontana, M. O. Bastos, and R. C. R. Beck, Development and validation of a fast RP-HPLC method for the determination of clobetasol propionate in topical nanocapsule suspensions. J. Chromatogr. Sci. (in press).
28. R. C. R. Beck, S. S. Guterres, R. J. Freddo, C. B. Michalowski, I. Barcellos, and J. A. Funck, Nanoparticles containing dexamethasone: Physicochemical properties and anti-inflammatory activity. Acta Farm. Bonaer. 22, 11 (2003).
29. International Conference on Harmonization (ICH), Validation of Analytical Procedures: Text and Methodology Q2(R1) (2005).
30. L. Cruz, L. U. Soares, T. Dalla Costa, G. Mezzalira, N. P. Silveira, S. S. Guterres, and A. R. Pohlmann, Diffusion and mathematical modeling of release profiles from nanocarriers. Int. J. Pharm. 313, 198 (2006).
31. P. J. Sinko, Chemical Kinetics and Stability, edited by P. J. Sinko, Martin's Physical Pharmacy and Pharmaceutical Sciences, Lippincott William & Wilkins, Baltimore (2006), pp. 396-434.
32. A. Jäger, V. Stefani, S. S. Guterres, and A. R. Pohlmann, Physicochemical characterization of nanocapsule polymeric wall using fluorescent benzazole probes. Int. J. Pharm. 338, 297 (2007).
33. N. J. Fox and G. W. Stachowiak, Vegetable oil-based lubricants - A review of oxidation. Tribol. Int. 40, 1035 (2007).
34. S. Y Redá, P. I. B. Carneiro, Óleos e gorduras: Aplicações e implicações. Rev. Anal. 27, 60 (2007).
35. S. R. Schaffazick, A. R. Pohlmann, and S. S. Guterres, Nanocapsules, nanoemulsion and nanodispersion containing melatonin: Preparation, characterization and stability evaluation. Pharmazie 62, 354 (2007).
36. R. B. Friedrich, M. C. Fontana, R. C. R. Beck, A. R. Pohlmann, and S. S. Guterres, Development and physicochemical characterization of dexamethasone-loaded polymeric nanocapsule suspensions. Quim. Nova 31, 1131 (2008).
37. C. Washington, Drug release from microdisperse systems: A critical review. Int. J. Pharm. 58, 1 (1990).
38. C. Losa, L. Marchal-Heussler, F. Orallo, J. L. V. Jato, M. J. Alonso, Design of new formulations for topical ocular administration: Polymeric nanocapsules containing metipranolol. Pharmaceut. Res. 10, 80 (1993).
39. M. Fresta, G. Cavallaro, G. Giammona, E. Wehrli, and G. Puglisi, Preparation and characterization of polyethyl-2-cyanoacrylate nanocapsules containing antiepileptic drugs. Biomaterials 17, 751 (1996).
40. M. Teixeira, M. J. Alonso, M. M. M. Pinto, and C. M. Barbosa, Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur. J. Pharm. Biopharm. 59, 491 (2005).
41. M. M. Jiménez, J. Pelletier, M. F. Bobin, and M. C. Martini, Influence of encapsulation on the in vitro percutaneous absorption of octyl methoxycinnamate. Int. J. Pharm. 272, 45 (2004).
42. N. S. Santos-Magalhães, A. Pontes, V. M. W. Pereira, and M. N. P. Caetano, Colloidal carriers for benzathine penivillin G: Nanoemulsions and nanocapsules. Int. J. Pharm. 208, 71 (2000).
43. F. S. Poletto, E. Jäger, L. Cruz, A. R. Pohlmann, and S. S. Guterres, The effect of polymeric wall on the permeability of drug-loaded nanocapsules. Mat. Sci. Eng. C 28, 472 (2008).
44. V. Ferranti, H. Marchais, C. Chabenat, A. M. Orecchioni, and O. Lafont, Primidone-loaded poly-ε-caprolactone nanocapsules: Incorporation efficiency and in vitro release profiles. Int. J. Pharm. 193, 107 (1999).
45. V. Weiss-Angeli, F. S. Poletto, L. R. Zancan, F. Baldasso, A. R. Pohlmann, and S. S. Guterres, Nanocapsules of octyl methoxycinnamate containing quercetin delayed the photodegradation of both components under ultraviolet A radiation. J. Biomed. Nanotechnol. 4, 80 (2008).